These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 15203157

  • 1. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Lehtonen JM, Parkkila S, Vullo D, Casini A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3757-62. PubMed ID: 15203157
    [Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
    Vullo D, Voipio J, Innocenti A, Rivera C, Ranki H, Scozzafava A, Kaila K, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):971-6. PubMed ID: 15686895
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.
    Turkmen H, Durgun M, Yilmaztekin S, Emul M, Innocenti A, Vullo D, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):367-72. PubMed ID: 15603956
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
    Vullo D, Innocenti A, Nishimori I, Pastorek J, Scozzafava A, Pastoreková S, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):963-9. PubMed ID: 15686894
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
    Vullo D, Scozzafava A, Pastorekova S, Pastorek J, Supuran CT.
    Bioorg Med Chem Lett; 2004 May 03; 14(9):2351-6. PubMed ID: 15081039
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT.
    J Med Chem; 1999 Jul 15; 42(14):2641-50. PubMed ID: 10411484
    [Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.
    Zimmerman S, Innocenti A, Casini A, Ferry JG, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Dec 20; 14(24):6001-6. PubMed ID: 15546717
    [Abstract] [Full Text] [Related]

  • 13. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
    Thiry A, Ledecq M, Cecchi A, Dogné JM, Wouters J, Supuran CT, Masereel B.
    J Med Chem; 2006 May 04; 49(9):2743-9. PubMed ID: 16640335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A, Winum JY, Innocenti A, Vullo D, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5775-80. PubMed ID: 15501039
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L, Fasolis G, Cecchi A, Winum JY, Gamberi A, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2359-64. PubMed ID: 15837325
    [Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
    Nishimori I, Minakuchi T, Onishi S, Vullo D, Cecchi A, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2007 Dec 01; 15(23):7229-36. PubMed ID: 17826101
    [Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors?
    Innocenti A, Maresca A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):3938-41. PubMed ID: 18572406
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.